Table 2 Factors influencing harm reported in the abstract
From: Abstracts in high profile journals often fail to report harm
| Â | cPR (CI95%) |
|---|---|
Funding* | Â |
   drug or device companies | 1 |
   public institutions | 0.77 (0.60 to 0.97) |
Placebo | Â |
   other control | 1 |
   placebo | 0.97 (0.81 to 1.13) |
Sample size | Â |
   less than 20 | 1 |
   equals or more than 200 | 1.14 (0.96 to 1.33) |
Direction of effect | Â |
   beneficial to intervention | 1 |
   neutral or against the intervention | 1.00 (0.83 to 1.19) |
Harm in text | Â |
   no harm in text | 1 |
   harm in text | 8.71 (5.90 to 12.01) |
Clinical significance of harm | Â |
   no mortality nor composite in text | 1 |
   mortality or composite in text | 1.43 (1.22 to 1.65) |
Harm in text statistically significant | Â |
   not statistically significant | 1 |
   statistically significant | 1.70 (1.47 to 1.92) |